Journal of Yeungnam Medical Science

Yeungnam University College of Medicine, Yeungnam University Institute Medical Science (영남대 의대 학술지 편집위원회)
권호 표지
DOI QR코드

DOI QR Code

Understanding insomnia as systemic disease

  • Yun, Seokho (Department of Psychiatry, Yeungnam University Hospital) ;
  • Jo, Sohye (Department of Psychiatry, Yeungnam University Hospital)
  • Received : 2021.08.08
  • Accepted : 2021.08.29
  • Published : 2021.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Sleep plays a critical role in homeostasis of the body and mind. Insomnia is a disease that causes disturbances in the initiation and maintenance of sleep. Insomnia is known to affect not only the sleep process itself but also an individual's cognitive function and emotional regulation during the daytime. It increases the risk of various neuropsychiatric diseases such as depression, anxiety disorder, and dementia. Although it might appear that insomnia only affects the nervous system, it is also a systemic disease that affects several aspects of the body, such as the cardiovascular, endocrine, and immune systems; therefore, it increases the risk of various diseases such as hypertension, diabetes mellitus, and infection. Insomnia has a wide range of effects on our bodies because sleep is a complex and active process. However, a high proportion of patients with insomnia do not seek treatment, which results in high direct and indirect costs. This is attributed to the disregard of many of the negative effects of insomnia. Therefore, we expect that understanding insomnia as a systemic disease will provide an opportunity to understand the condition better and help prevent secondary impairment due to insomnia.

Keywords

References

  1. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Arlington, VA: APA; 2013.
  2. Aernout E, Benradia I, Hazo JB, Sy A, Askevis-Leherpeux F, Sebbane D, et al. International study of the prevalence and factors associated with insomnia in the general population. Sleep Med 2021;82:186-92. https://doi.org/10.1016/j.sleep.2021.03.028
  3. LeBlanc M, Merette C, Savard J, Ivers H, Baillargeon L, Morin CM. Incidence and risk factors of insomnia in a population-based sample. Sleep 2009;32:1027-37. https://doi.org/10.1093/sleep/32.8.1027
  4. Taddei-Allen P. Economic burden and managed care considerations for the treatment of insomnia. Am J Manag Care 2020; 26(4 Suppl):S91-6. https://doi.org/10.37765/ajmc.2020.43008
  5. Harvey AG. Insomnia: symptom or diagnosis? Clin Psychol Rev 2001;21:1037-59. https://doi.org/10.1016/S0272-7358(00)00083-0
  6. Fernandez-Mendoza J, Vgontzas AN. Insomnia and its impact on physical and mental health. Curr Psychiatry Rep 2013;15:418. https://doi.org/10.1007/s11920-013-0418-8
  7. Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev 2012;16:83-94. https://doi.org/10.1016/j.smrv.2011.03.008
  8. Brownlow JA, Miller KE, Gehrman PR. Insomnia and cognitive performance. Sleep Med Clin 2020;15:71-6. https://doi.org/10.1016/j.jsmc.2019.10.002
  9. Nissen C, Kloepfer C, Nofzinger EA, Feige B, Voderholzer U, Riemann D. Impaired sleep-related memory consolidation in primary insomnia: a pilot study. Sleep 2006;29:1068-73. https://doi.org/10.1093/sleep/29.8.1068
  10. Backhaus J, Junghanns K, Born J, Hohaus K, Faasch F, Hohagen F. Impaired declarative memory consolidation during sleep in patients with primary insomnia: influence of sleep architecture and nocturnal cortisol release. Biol Psychiatry 2006;60:1324-30. https://doi.org/10.1016/j.biopsych.2006.03.051
  11. Drummond SP, Walker M, Almklov E, Campos M, Anderson DE, Straus LD. Neural correlates of working memory performance in primary insomnia. Sleep 2013;36:1307-16. https://doi.org/10.5665/sleep.2952
  12. Vignola A, Lamoureux C, Bastien CH, Morin CM. Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adults. J Gerontol B Psychol Sci Soc Sci 2000;55:P54-62.
  13. Bonnet MH, Arand DL. 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995;18:581-8. https://doi.org/10.1093/sleep/18.7.581
  14. Shekleton JA, Rogers NL, Rajaratnam SM. Searching for the daytime impairments of primary insomnia. Sleep Med Rev 2010;14:47-60. https://doi.org/10.1016/j.smrv.2009.06.001
  15. Shallice T, Stuss DT, Alexander MP, Picton TW, Derkzen D. The multiple dimensions of sustained attention. Cortex 2008;44:794-805. https://doi.org/10.1016/j.cortex.2007.04.002
  16. Hauri PJ. Cognitive deficits in insomnia patients. Acta Neurol Belg 1997;97:113-7.
  17. Altena E, Van Der Werf YD, Strijers RL, Van Someren EJ. Sleep loss affects vigilance: effects of chronic insomnia and sleep therapy. J Sleep Res 2008;17:335-43. https://doi.org/10.1111/j.1365-2869.2008.00671.x
  18. Edinger JD, Means MK, Carney CE, Krystal AD. Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia. Sleep 2008;31:599-607. https://doi.org/10.1093/sleep/31.5.599
  19. Edinger JD, Glenn DM, Bastian LA, Marsh GR. Slow-wave sleep and waking cognitive performance II: findings among middle-aged adults with and without insomnia complaints. Physiol Behav 2000;70:127-34. https://doi.org/10.1016/S0031-9384(00)00238-9
  20. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999;22(Suppl 2):S354-8.
  21. Vasisht KP, Kessler LE, Booth JN 3rd, Imperial JG, Penev PD. Differences in insulin secretion and sensitivity in short-sleep insomnia. Sleep 2013;36:955-7. https://doi.org/10.5665/sleep.2734
  22. Guo H, Wei M, Ding W. Changes in cognitive function in patients with primary insomnia. Shanghai Arch Psychiatry 2017;29:137-45.
  23. Fortier-Brochu E, Morin CM. Cognitive impairment in individuals with insomnia: clinical significance and correlates. Sleep 2014;37:1787-98. https://doi.org/10.5665/sleep.4172
  24. Fulda S, Schulz H. Cognitive dysfunction in sleep disorders. Sleep Med Rev 2001;5:423-45. https://doi.org/10.1053/smrv.2001.0157
  25. Gruber R, Cassoff J. The interplay between sleep and emotion regulation: conceptual framework empirical evidence and future directions. Curr Psychiatry Rep 2014;16:500. https://doi.org/10.1007/s11920-014-0500-x
  26. Kyle SD, Beattie L, Spiegelhalder K, Rogers Z, Espie CA. Altered emotion perception in insomnia disorder. Sleep 2014;37:775-83. https://doi.org/10.5665/sleep.3588
  27. McCrae CS, McNamara JP, Rowe MA, Dzierzewski JM, Dirk J, Marsiske M, et al. Sleep and affect in older adults: using multilevel modeling to examine daily associations. J Sleep Res 2008;17:42-53. https://doi.org/10.1111/j.1365-2869.2008.00621.x
  28. Scott BA, Judge TA. Insomnia, emotions, and job satisfaction: a multilevel study. J Manag 2006;32:622-45. https://doi.org/10.1177/0149206306289762
  29. Huang Z, Liang P, Jia X, Zhan S, Li N, Ding Y, et al. Abnormal amygdala connectivity in patients with primary insomnia: evidence from resting state fMRI. Eur J Radiol 2012;81:1288-95. https://doi.org/10.1016/j.ejrad.2011.03.029
  30. Harvey AG. I can't sleep, my mind is racing! An investigation of strategies of thought control in insomnia. Behav Cogn Psychother 2001;29:3-11. https://doi.org/10.1017/s1352465801001023
  31. Markarian SA, Pickett SM, Deveson DF, Kanona BB. A model of BIS/BAS sensitivity, emotion regulation difficulties, and depression, anxiety, and stress symptoms in relation to sleep quality. Psychiatry Res 2013;210:281-6. https://doi.org/10.1016/j.psychres.2013.06.004
  32. Kamphuis J, Dijk DJ, Spreen M, Lancel M. The relation between poor sleep, impulsivity and aggression in forensic psychiatric patients. Physiol Behav 2014;123:168-73. https://doi.org/10.1016/j.physbeh.2013.10.015
  33. Ingjaldsson JT, Laberg JC, Thayer JF. Reduced heart rate variability in chronic alcohol abuse: relationship with negative mood, chronic thought suppression, and compulsive drinking. Biol Psychiatry 2003;54:1427-36. https://doi.org/10.1016/S0006-3223(02)01926-1
  34. Craig AD. Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol 2003;13:500-5. https://doi.org/10.1016/S0959-4388(03)00090-4
  35. Wei Y, Ramautar JR, Colombo MA, Stoffers D, Gomez-Herrero G, van der Meijden WP, et al. I keep a close watch on this heart of mine: increased interoception in insomnia. Sleep 2016;39:2113-24. https://doi.org/10.5665/sleep.6308
  36. Paulus MP, Stein MB. Interoception in anxiety and depression. Brain Struct Funct 2010;214:451-63. https://doi.org/10.1007/s00429-010-0258-9
  37. Stephan KE, Manjaly ZM, Mathys CD, Weber LA, Paliwal S, Gard T, et al. Allostatic self-efficacy: a metacognitive theory of dyshomeostasis-induced fatigue and depression. Front Hum Neurosci 2016;10:550. https://doi.org/10.3389/fnhum.2016.00550
  38. Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep 2007;30:213-8. https://doi.org/10.1093/sleep/30.2.213
  39. Ettensohn M, Soto Y, Bassi B, Khurshid KA. Sleep problems and disorders in patients with depression. Psychiatr Ann 2016;46:390-5. https://doi.org/10.3928/00485713-20160502-01
  40. Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ. Insomnia in young men and subsequent depression: the Johns Hopkins Precursors Study. Am J Epidemiol 1997;146:105-14. https://doi.org/10.1093/oxfordjournals.aje.a009241
  41. Khurshid KA. Comorbid insomnia and psychiatric disorders: an update. Innov Clin Neurosci 2018;15:28-32.
  42. Thase ME. Depression, sleep, and antidepressants. J Clin Psychiatry 1998;59(Suppl 4):55-65. https://doi.org/10.4088/JCP.v59n1002
  43. Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci 2008;10:473-81. https://doi.org/10.31887/DCNS.2008.10.4/plfranzen
  44. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 1997;31:333-46. https://doi.org/10.1016/S0022-3956(97)00002-2
  45. de Almondes KM, Costa MV, Malloy-Diniz LF, Diniz BS. Insomnia and risk of dementia in older adults: systematic review and meta-analysis. J Psychiatr Res 2016;77:109-15. https://doi.org/10.1016/j.jpsychires.2016.02.021
  46. Chen PL, Lee WJ, Sun WZ, Oyang YJ, Fuh JL. Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS One 2012;7:e49113. https://doi.org/10.1371/journal.pone.0049113
  47. Bombois S, Derambure P, Pasquier F, Monaca C. Sleep disorders in aging and dementia. J Nutr Health Aging 2010;14:212-7. https://doi.org/10.1007/s12603-010-0052-7
  48. Monroe LJ. Psychological and physiological differences between good and poor sleepers. J Abnorm Psychol 1967;72:255-64. https://doi.org/10.1037/h0024563
  49. Roth T, Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone 2003;5:5-15. https://doi.org/10.1016/S1098-3597(03)90031-7
  50. Levenson JC, Kay DB, Buysse DJ. The pathophysiology of insomnia. Chest 2015;147:1179-92. https://doi.org/10.1378/chest.14-1617
  51. Morris CJ, Aeschbach D, Scheer FA. Circadian system, sleep and endocrinology. Mol Cell Endocrinol 2012;349:91-104. https://doi.org/10.1016/j.mce.2011.09.003
  52. Morgan D, Tsai SC. Sleep and the endocrine system. Crit Care Clin 2015;31:403-18. https://doi.org/10.1016/j.ccc.2015.03.004
  53. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 2001;86:3787-94. https://doi.org/10.1210/jc.86.8.3787
  54. Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes 2010;59:2126-33. https://doi.org/10.2337/db09-0699
  55. Yamamoto N, Yamanaka G, Ishizawa K, Ishikawa M, Murakami S, Yamanaka T, et al. Insomnia increases insulin resistance and insulin secretion in elderly people. J Am Geriatr Soc 2010;58:801-4. https://doi.org/10.1111/j.1532-5415.2010.02794.x
  56. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004;1:e62. https://doi.org/10.1371/journal.pmed.0010062
  57. Motivala SJ, Tomiyama AJ, Ziegler M, Khandrika S, Irwin MR. Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia. Psychoneuroendocrinology 2009;34:540-5. https://doi.org/10.1016/j.psyneuen.2008.10.016
  58. Hajak G, Rodenbeck A, Staedt J, Bandelow B, Huether G, Ruther E. Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia. J Pineal Res 1995;19:116-22. https://doi.org/10.1111/j.1600-079X.1995.tb00179.x
  59. Bryant PA, Trinder J, Curtis N. Sick and tired: does sleep have a vital role in the immune system? Nat Rev Immunol 2004;4:457-67. https://doi.org/10.1038/nri1369
  60. Imeri L, Opp MR. How (and why) the immune system makes us sleep. Nat Rev Neurosci 2009;10:199-210. https://doi.org/10.1038/nrn2576
  61. Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 2010;14:19-31. https://doi.org/10.1016/j.smrv.2009.04.002
  62. Parthasarathy S, Vasquez MM, Halonen M, Bootzin R, Quan SF, Martinez FD, et al. Persistent insomnia is associated with mortality risk. Am J Med 2015;128:268-75. https://doi.org/10.1016/j.amjmed.2014.10.015
  63. Baglioni C, Regen W, Teghen A, Spiegelhalder K, Feige B, Nissen C, et al. Sleep changes in the disorder of insomnia: a meta-analysis of polysomnographic studies. Sleep Med Rev 2014;18:195-213. https://doi.org/10.1016/j.smrv.2013.04.001
  64. Oh DY, Park SM, Choi SW. Daytime neurophysiological hyperarousal in chronic insomnia: a study of qEEG. J Clin Med 2020;9:3425. https://doi.org/10.3390/jcm9113425
  65. Cortoos A, De Valck E, Pattyn N, Mairesse O, Cluydts R. Excitatory versus inhibitory impairments in insomnia patients: an ERP study. Int J Psychophysiol 2014;93:62-9. https://doi.org/10.1016/j.ijpsycho.2013.03.004
  66. Bollu PC, Kaur H. Sleep medicine: insomnia and sleep. Mo Med 2019;116:68-75.
  67. Javaheri S, Redline S. Insomnia and risk of cardiovascular disease. Chest 2017;152:435-44. https://doi.org/10.1016/j.chest.2017.01.026
  68. Spiegelhalder K, Scholtes C, Riemann D. The association between insomnia and cardiovascular diseases. Nat Sci Sleep 2010;2:71-8. https://doi.org/10.2147/NSS.S7471
  69. Hsu CY, Chen YT, Chen MH, Huang CC, Chiang CH, Huang PH, et al. The association between insomnia and increased future cardiovascular events: a nationwide population-based study. Psychosom Med 2015;77:743-51. https://doi.org/10.1097/PSY.0000000000000199
  70. Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol 2014;21:57-64. https://doi.org/10.1177/2047487312460020
  71. Hsieh CG, Martin JL. Short sleep, insomnia, and cardiovascular disease. Curr Sleep Med Rep 2019;5:234-42. https://doi.org/10.1007/s40675-019-00157-8
  72. Lin CL, Chien WC, Chung CH, Wu FL. Risk of type 2 diabetes in patients with insomnia: a population-based historical cohort study. Diabetes Metab Res Rev 2018;34:e2930. https://doi.org/10.1002/dmrr.2930
  73. Johnson KA, Gordon CJ, Chapman JL, Hoyos CM, Marshall NS, Miller CB, et al. The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: a systematic review and meta-analysis. Sleep Med Rev 2021;59:101456. https://doi.org/10.1016/j.smrv.2021.101456
  74. Xia L, Chen GH, Li ZH, Jiang S, Shen J. Alterations in hypothalamus-pituitary-adrenal/thyroid axes and gonadotropin-releasing hormone in the patients with primary insomnia: a clinical research. PLoS One 2013;8:e71065. https://doi.org/10.1371/journal.pone.0071065
  75. Cronlein T. Insomnia and obesity. Curr Opin Psychiatry 2016;29:409-12. https://doi.org/10.1097/YCO.0000000000000284
  76. Chan WS, Levsen MP, McCrae CS. A meta-analysis of associations between obesity and insomnia diagnosis and symptoms. Sleep Med Rev 2018;40:170-82. https://doi.org/10.1016/j.smrv.2017.12.004
  77. Nieters A, Blagitko-Dorfs N, Peter HH, Weber S. Psychophysiological insomnia and respiratory tract infections: results of an infection-diary-based cohort study. Sleep 2019;42:zsz098. https://doi.org/10.1093/sleep/zsz098
  78. Ruel S, Ivers H, Savard MH, Gouin JP, Lemieux J, Provencher L, et al. Insomnia, immunity, and infections in cancer patients: results from a longitudinal study. Health Psychol 2020;39:358-69. https://doi.org/10.1037/hea0000811
  79. Blask DE. Melatonin, sleep disturbance and cancer risk. Sleep Med Rev 2009;13:257-64. https://doi.org/10.1016/j.smrv.2008.07.007
  80. Fang HF, Miao NF, Chen CD, Sithole T, Chung MH. Risk of cancer in patients with insomnia, parasomnia, and obstructive sleep apnea: a nationwide nested case-control study. J Cancer 2015;6:1140-7. https://doi.org/10.7150/jca.12490
  81. Sen A, Opdahl S, Strand LB, Vatten LJ, Laugsand LE, Janszky I. Insomnia and the risk of breast cancer: the HUNT study. Psychosom Med 2017;79:461-8. https://doi.org/10.1097/PSY.0000000000000417
  82. Shi T, Min M, Sun C, Zhang Y, Liang M, Sun Y. Does insomnia predict a high risk of cancer? A systematic review and meta-analysis of cohort studies. J Sleep Res 2020;29:e12876. https://doi.org/10.1111/jsr.12876
  83. Vyazovskiy VV, Delogu A. NREM and REM Sleep: complementary roles in recovery after wakefulness. Neuroscientist 2014;20:203-19. https://doi.org/10.1177/1073858413518152
  84. Leger D, Debellemaniere E, Rabat A, Bayon V, Benchenane K, Chennaoui M. Slow-wave sleep: from the cell to the clinic. Sleep Med Rev 2018;41:113-32. https://doi.org/10.1016/j.smrv.2018.01.008
  85. Peever J, Fuller PM. The biology of REM sleep. Curr Biol 2017; 27:R1237-48. https://doi.org/10.1016/j.cub.2017.10.026
  86. Kucharczyk ER, Morgan K, Hall AP. The occupational impact of sleep quality and insomnia symptoms. Sleep Med Rev 2012;16:547-59. https://doi.org/10.1016/j.smrv.2012.01.005
  87. Okajima I, Chen J. The effect of insomnia on changes in anxiety, depression, and social function after a transdiagnostic treatment targeting excessive worry. Sleep Biol Rhythm 2017;15:243-9. https://doi.org/10.1007/s41105-017-0102-1
  88. Ishak WW, Bagot K, Thomas S, Magakian N, Bedwani D, Larson D, et al. Quality of life in patients suffering from insomnia. Innov Clin Neurosci 2012;9:13-26.
  89. Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007;30:263-73. https://doi.org/10.1093/sleep/30.3.263
  90. Matteson-Rusby SE, Pigeon WR, Gehrman P, Perlis ML. Why treat insomnia? Prim Care Companion J Clin Psychiatry 2010;12:PCC.08r00743. https://doi.org/10.4088/PCC.08r00743bro

Cited by

  1. Understanding sleep and sleep disturbances in autism spectrum disorder, and management of insomnia: an update vol.38, pp.4, 2021, https://doi.org/10.12701/yujm.2021.01459